The present invention provides soluble single wall nanotube (SWNT) constructs functionalized with a plurality of a targeting moiety and a plurality of one or more payload molecules attached thereto. The targeting moiety and the payload molecules may be attached to the soluble SWNT via a DNA or other oligomer platform attached to the SWNT. These soluble SWNT constructs may comprise a radionuclide or contrast agent and as such are effective as diagnostic and therapeutic agents. Methods provided herein are to diagnosing or locating a cancer, treating a cancer, eliciting an immune response against a cancer or delivering an anticancer drug in situ via an enzymatic nanofactory using the soluble SWNT constructs.

The present invention provides soluble single wall nanotube (SWNT) constructs functionalized with a plurality of a targeting moiety and a plurality of one or more payload molecules attached thereto. The targeting moiety and the payload molecules may be attached to the soluble SWNT via a DNA or other oligomer platform attached to the SWNT. These soluble SWNT constructs may comprise a radionuclide or contrast agent and as such are effective as diagnostic and therapeutic agents. Methods provided herein are to diagnosing or locating a cancer, treating a cancer, eliciting an immune response against a cancer or delivering an anticancer drug in situ via an enzymatic nanofactory using the soluble SWNT constructs.

A method of making a carbon nanotube bundle is provided. A plurality of carbon nanotubes is provided. A plurality of sulfur nanoparticles is disposed on the plurality of carbon nanotubes to form at least two visible carbon nanotubes. The at least two visible carbon nanotubes are stacked to form a carbon nanotube bundle preparation body. The plurality of sulfur nanoparticles in the carbon nanotube bundle preparation body is removed to obtain the carbon nanotube bundle.

A method of making a carbon nanotube bundle is provided. A plurality of carbon nanotubes is provided. A plurality of sulfur nanoparticles is disposed on the plurality of carbon nanotubes to form at least two visible carbon nanotubes. The at least two visible carbon nanotubes are stacked to form a carbon nanotube bundle preparation body. The plurality of sulfur nanoparticles in the carbon nanotube bundle preparation body is removed to obtain the carbon nanotube bundle.

The present disclosure provides scalable nanotube fabrics and methods for controlling or otherwise adjusting the nanotube length distribution of a nanotube application solution in order to realize scalable nanotube fabrics. In one aspect of the present disclosure, one or more filtering operations are used to remove relatively long nanotube elements from a nanotube solution until nanotube length distribution of the nanotube solution conforms to a preselected or desired nanotube length distribution profile. In another aspect of the present disclosure, a sono-chemical cutting process is used to break up relatively long nanotube elements within a nanotube application solution into relatively short nanotube elements to realize a pre-selected or desired nanotube length distribution profile.

The present disclosure provides scalable nanotube fabrics and methods for controlling or otherwise adjusting the nanotube length distribution of a nanotube application solution in order to realize scalable nanotube fabrics. In one aspect of the present disclosure, one or more filtering operations are used to remove relatively long nanotube elements from a nanotube solution until nanotube length distribution of the nanotube solution conforms to a preselected or desired nanotube length distribution profile. In another aspect of the present disclosure, a sono-chemical cutting process is used to break up relatively long nanotube elements within a nanotube application solution into relatively short nanotube elements to realize a pre-selected or desired nanotube length distribution profile.

One or more techniques are disclosed for a method of functionalizing graphitic material, comprising the steps of: 1) providing a graphitic material; 2) cutting the graphitic material; 3) providing a catalyst comprising at least one catalyst of a metal atom, metal cation, metal alcoholates, metal alkanoates, metal sulfonates, and metal powder; 4) providing a reagent; 5) binding the catalyst to the reagent; 6) binding the reagent to the graphitic material; and 7) recovering the catalyst. Also disclosed is a composition prepared from the methods described herein.

One or more techniques are disclosed for a method of functionalizing graphitic material, comprising the steps of: 1) providing a graphitic material; 2) cutting the graphitic material; 3) providing a catalyst comprising at least one catalyst of a metal atom, metal cation, metal alcoholates, metal alkanoates, metal sulfonates, and metal powder; 4) providing a reagent; 5) binding the catalyst to the reagent; 6) binding the reagent to the graphitic material; and 7) recovering the catalyst. Also disclosed is a composition prepared from the methods described herein.

Template-guided growth of carbon nanotubes using anodized aluminum oxide nanopore templates provides vertically aligned, untangled planarized arrays of multiwall carbon nanotubes with Ohmic back contacts. Growth by catalytic chemical vapor deposition results in multiwall carbon nanotubes with uniform diameters and crystalline quality, but varying lengths. The nanotube lengths can be trimmed to uniform heights above the template surface using ultrasonic cutting, for example. The carbon nanotube site density can be controlled by controlling the catalyst site density. Control of the carbon nanotube site density enables various applications. For example, the highest possible site density is preferred for thermal interface materials, whereas, for field emission, significantly lower site densities are preferable.

Provided herein is a nanopore structure, which in one aspect is a “carbon nanotube porin”, that comprises a short nanotube with an associated lipid coating. Also disclosed are compositions and methods enabling the preparation of such nanotube/lipid complexes. Further disclosed is a method for therapeutics delivery that involves a drug delivery agent comprising a liposome with a NT loaded with a therapeutic agent, introducing the therapeutic agent into a cell or a tissue or an organism; and subsequent release of the therapeutic agents into a cell.